NIH R01 · 2024
Guanfacine for women with AUD: A multisite study using a telehealth approach
ABSTRACT There is currently a dearth of FDA-approved medications developed specifically for women with alcohol use disorder (AUD). This represents a major public health concern for several reasons. First, robust sex- and gender-related differences set women at a marked disadvantage for progressing to severe AUD more quickly than men (telescoping). Second, alcohol consumption levels in women have been steadily moving towards parity with men. Third, women with AUD remain challenging to recruit into research trials, as many have caregiving commitments and/or feel stigmatized. Together these factors compound the need to develop new relapse prevention medications tailored to women, using methods…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.